What does this video actually claim?
Andrew Bernie Bernard (@_whatmakesaman_) posted a brief video saying "No no no" with hashtags about gym culture, toxic masculinity, steroids, and low testosterone. Without seeing the actual video content, the hashtags suggest he's responding to something about TRT or steroid use in fitness culture.
The caption is minimal, but the hashtag combination implies he's pushing back against either TRT stigma or steroid normalization. This kind of content often emerges in response to other posts about hormone therapy.
What's the real story with TRT?
Testosterone replacement therapy isn't the same as anabolic steroid abuse, despite social media often conflating them. The Testosterone Trials (Snyder et al., NEJM, 2016) studied 790 men over 65 with testosterone levels below 275 ng/dL and found modest improvements in sexual function and mood.
TRT prescription rates have increased 300% since 2001 according to Baillargeon et al. (JAMA, 2013), but many prescriptions go to men without clear hypogonadism. The FDA requires confirmed low testosterone (typically under 300 ng/dL) on two separate morning tests plus symptoms.
The therapy works differently than supraphysiologic steroid doses. TRT aims to restore normal levels (300-1000 ng/dL), while steroid cycles often push levels to 2000+ ng/dL.
Where does gym culture get it wrong?
Social media fitness culture often presents false binaries about TRT. It's either demonized as cheating or promoted as a fountain of youth. Neither extreme reflects clinical reality.
The Testim Registry study (Kathryn et al., 2014) followed 1,031 men and found TRT helped with energy and libido in truly hypogonadal men, but results were modest. You won't transform into a different person.
Bernard's "no no no" reaction might be appropriate if he's countering either extreme. TRT isn't a shortcut to superhuman performance, but it's also not inherently toxic masculinity when prescribed appropriately.
What should you actually know?
TRT carries real risks that gym culture often ignores. The TRAVERSE trial (Lincoff et al., NEJM, 2023) followed 5,246 men for a median of 33 months and found no increased cardiovascular risk compared to placebo, settling a long-standing safety debate.
However, TRT suppresses natural testosterone production and can affect fertility. It may worsen sleep apnea and increase red blood cell count. These aren't deal-breakers but require monitoring.
The bigger issue is overdiagnosis. Many men seeking TRT have normal testosterone but symptoms from poor sleep, stress, or other factors that hormone therapy won't fix.